Search for: "Ranbaxy Inc"
Results 21 - 40
of 142
Sorted by Relevance
|
Sort by Date
25 Mar 2008, 9:57 am
Pfizer has filed two patent infringement cases against Ranbaxy at Delaware District court. [read post]
24 Dec 2008, 9:04 am
Earlier, Schering and Sepracor have similar settlement agreements with generic manufacturers including Ranbaxy, Perrigo Co. and Watson Pharmaceuticals Inc. [read post]
30 Sep 2013, 8:12 am
District Court for the District of Delaware against Apotex Corp.; Hetero USA Inc.; Lupin Ltd.; Mylan Pharmaceuticals, Inc.; Par Pharmaceuticals, Inc.; Ranbaxy Laboratories Ltd.; and related companies and subsidiaries. [read post]
3 May 2011, 7:16 am
Mylan Pharmaceuticals Inc. has lost its bid in Washington federal court to force a U.S. [read post]
16 Jul 2010, 7:14 am
Ranbaxy Laboratories Inc., 2-10-cv-00121 (TXED July 14, 2010, Report & Recommendations) (Everingham, M.J.) [read post]
18 May 2020, 8:38 am
Ranbaxy Pharm., Inc., 336 F.3d 1322, 1330(Fed. [read post]
17 Aug 2009, 8:01 am
And lest we forget, India’s Ranbaxy also produces a generic form of Adderall. [read post]
17 Aug 2009, 8:01 am
And lest we forget, India’s Ranbaxy also produces a generic form of Adderall. [read post]
23 Oct 2013, 4:17 am
On October 23, the long-term care pharmacy giant Omnicare, Inc., filed an 8-K statement with the SEC disclosing that it had reached an agreement in principle to settle allegations of kickbacks raised by a qui tam relator in the Northern District of Ohio, for $120 million. [read post]
16 Apr 2018, 2:48 pm
Bard, Inc. v. [read post]
3 Mar 2012, 9:45 am
In an article titled Sector Snap: Generic competition and biotech drugs , one notes the irony that generic maker Teva is facing Hatch-Waxman challenges from Mylan Inc. and Novartis AG over its patented drug Copaxone, a drug for treatment of multiple sclerosis. [read post]
22 Jul 2011, 12:31 pm
Ranbaxy Laboratories, Inc., No. 10-793 (E.D. [read post]
25 Oct 2007, 7:17 am
Putney, Inc. v. [read post]
13 Sep 2013, 7:43 am
The largest settlement this year involved Ranbaxy, Inc., based in Princeton New Jersey. [read post]
12 Jul 2013, 11:00 am
More Than $34 Million to Resolve False Claims Act Allegations Related to Kyphoplasty, Justice.gov, July 2, 2013 Medtronic Spine, Formerly Kyphon Inc., to Pay U.S. $75 Million to Resolve Allegations of Defrauding Medicare, Justice.gov, May 22, 2008 More Blog Posts:Nursing Home to Pay $2.7M for Medicaid Fraud Claims Brought to Light By Whistleblower, Boston Injury Lawyer Blog, March 23, 2013 Whistleblower Lawsuit Accuses Dialysis Company DaVita Inc. of Overbilling Medicare and… [read post]
1 Sep 2010, 6:49 am
Apotex, Inc. [read post]
28 Jan 2012, 6:23 am
Any hopes that consumers of generic drugs would be protected by the FDA’s own oversight of generic drug manufacturing came to a crashing halt earlier this week when the Department of Justice and the Food and Drug Administration jointly announced their Consent Decree with Ranbaxy Laboratories: Through investigation by the department and the FDA, the government uncovered numerous problems with Ranbaxy’s drug manufacturing and testing in India and at facilities owned by… [read post]
27 Aug 2017, 10:01 pm
Actavis, Inc. [read post]
27 Aug 2017, 10:01 pm
Actavis, Inc. [read post]
24 May 2021, 7:34 am
The plaintiffs have accused Ranbaxy of delaying the launch of generic versions of Novartis AG’s high blood pressure drug Diovan, Pfizer Inc’s acid reflux drug Nexium and Genentech Inc’s antiviral drug Valcyte. [read post]
